Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 8, 2012 - Issue 9: Special Focus: Cancer Commentary Series. Guest Editors: Michael G. Hanna and Alex Kudrin
Submit an article Journal homepage
2,235
Views
14
CrossRef citations to date
0
Altmetric
Research Paper

Production and evaluation of a chromatographically purified Vero cell rabies vaccine (PVRV) in China using microcarrier technology

Pengcheng Yu State Key Laboratory for Infectious Disease Prevention and Control, Institute for Viral Disease Control and Prevention; Beijing, P. R. China
,
Ying Huang State Key Laboratory for Infectious Disease Prevention and Control, Institute for Viral Disease Control and Prevention; Beijing, P. R. China
,
Yibin Zhang Liaoning Chengda Biology Co., Ltd; Hai Dian District; Beijing, P. R. China
,
Qing Tang State Key Laboratory for Infectious Disease Prevention and Control, Institute for Viral Disease Control and Prevention; Beijing, P. R. ChinaCorrespondence[email protected]
&
Guodong Liang State Key Laboratory for Infectious Disease Prevention and Control, Institute for Viral Disease Control and Prevention; Beijing, P. R. China
Pages 1230-1235 | Received 22 Mar 2012, Accepted 03 Jun 2012, Published online: 16 Aug 2012

References

  • Cui-ping Y, Hang Z, Hui W, Xinxin S, Lihua W, Wenwu Y, et al. Epidemiological analysis of rabies in 2010, China. Chinese Journal of Experimental and Clinical Virology 2011; 25:434 - 6
  • Situation of rabies prevention and control in China. Ministry of Health of the People’s Republic of China 2009.
  • Yongxin Y. Development of the current situation of the domestic and foreign rabies vaccine. Shanghai Journal of Preventive Medicine 2006; 18:216 - 8
  • Li C, Jun G, Jianying H, Zhumu B, Deming Y, Junwei Y, et al. Preparation of Rabies Vaccine for Human Use by Cell Culture in Bioreactor. Chinese Journal of Biologicals 2006; 19:288 - 90
  • CytodexTM 1: Beaded microcarriers for cell culture, Pharmacia Fine Chemicals, Technical Booklet Series, Uppsala, Sweden 1978.
  • Kruse PF Patterson MK. Tissue culture, methods and applications. New York: Academic Press, 1973; 372-377.
  • van Wezel AL, van Herwaarden JA, van de Heuvel-de Rijk EW. Large-scale concentration and purification of virus suspension from microcarrier culture for the preparation of inactivated virus vaccines. Dev Biol Stand 1979; 42:65 - 9; PMID: 223923
  • Yan-ping L, Li C, Rong-cheng L, Jiongxian T, Yi N, Fusheng C, et al. Safety and immunogenicity of a new inactivated rabies vaccine (Vero Cell) in healthy adult. Guangxi Prev Med 2005; 11:193 - 5
  • WHO expert consultation on rabies: first report. WHO technical report series 931. Geneva: WHO; 2004.
  • Smith JS, Yager PA, Baer GM. A rapid reproducible test for determining rabies neutralizing antibody. Bull World Health Organ 1973; 48:535 - 41; PMID: 4544144
  • WHO expert consultation on rabies, 1st report. Geneva 2005; 88.
  • WHO tech Rep Ser No. 700, 1984.
  • WHO tech Rep Ser No. 747, 1987.
  • Wang LY, Sun MP, Zhang XC, Suo LD, Xu RH, Zou YJ, et al. Safety and immunogenicity of two freeze-dried Vero cell rabies vaccines for human use in post-exposure prophylaxis. Vaccine 2011; 29:2679 - 81; http://dx.doi.org/10.1016/j.vaccine.2011.01.053; PMID: 21296694
  • Liu H, Huang G, Tang Q, Li J, Cao S, Fu C, et al. The immunogenicity and safety of vaccination with purified Vero cell rabies vaccine (PVRV) in China under a 2-1-1 regimen. Hum Vaccin 2011; 7:220 - 4; http://dx.doi.org/10.4161/hv.7.2.14003; PMID: 21311216
  • Meslin FX, Kaplan MM, Koprowski H. Laboratory techniques in rabies. 4th edition. Geneva: World Health Organization, 1996: 7.
  • Fishbein DB, Yenne KM, Dreesen DW, Teplis CF, Mehta N, Briggs DJ. Risk factors for systemic hypersensitivity reactions after booster vaccinations with human diploid cell rabies vaccine: a nationwide prospective study. Vaccine 1993; 11:1390 - 4; http://dx.doi.org/10.1016/0264-410X(93)90167-V; PMID: 8310759
  • Suntharasamai P, Chaiprasithikul P, Wasi C, Supanaranond W, Auewarakul P, Chanthavanich P, et al. A simplified and economical intradermal regimen of purified chick embryo cell rabies vaccine for postexposure prophylaxis. Vaccine 1994; 12:508 - 12; http://dx.doi.org/10.1016/0264-410X(94)90308-5; PMID: 8036824

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.